Table 3.
Demographics of late effects (N = 37 events; N = 29 patients)
| Median time to late toxicity | 192 days (range 91-483 days) |
|---|---|
| Primary v recurrent v metastatic disease | N=29 |
| Primary | 11 |
| Recurrent | 12 |
| Metastatic | 6 |
| Prescription dose | N=29 |
| 45 Gy/5# | 1 |
| 48 Gy/4# | 5 |
| 50 Gy/1o0# | 1 |
| 50 Gy/5# | 9 |
| 54 Gy/3# | 10 |
| 60 Gy/3# | 3 |
| Prior definitive EBRT | N=29 |
| Yes | 8 |
| No | 21 |
| Grade toxicity | N=37 |
| 1 | 18 |
| 2 | 15 |
| 3 | 3 |
| 5 | 1 (one patient died of pneumonitis at d162) |
| Type of toxicity | N=37 |
| Chest wall pain | 6 |
| Lymphedema | 1 |
| Cough | 6 |
| Dyspnea | 13 |
| Vocal cord paralysis | 1 |
| Fatigue | 2 |
| Pneumonitis (>90 days) | 5 |
| Hemoptysis | 1 |
| Necrosis | 1 |
| Rib fracture | 1 |
| Number of courses SBRT per patient | N=29 |
| 1 | 10 |
| 2 | 13 |
| 3 | 6 |
| Number of sites treated per patient | N=29 |
| 2 | 18 |
| 3 | 8 |
| 4 | 3 |
| Number who had 2 sites treated at once/split over short period of time between 2 courses | N=12 |